Contact this trialFirst, we need to learn more about you.
PI3K inhibitor
Copanlisib + EPOCH-R for High-Grade B-cell Lymphoma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial tests if a combo of drugs can help treat aggressive B-cell lymphomas. Eligible participants must be 18+. Screening tests & tissue/fluid samples will be collected. Treatment given in 21-day cycles, followed by at least 5 yrs of follow-up.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.